AREXVY subst sèche c solv flac
7680693100015
CH-69310
J07BX05
08.08.
1 / 3
google
Details
- Product number
- 6931001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- I): proteinum prae-fusionatum F viri sincitialis respiratorii 120 µg, trehalosum dihydricum, polysorbatum 80, kalii dihydrogenophosphas, dikalii phosphas anhydricus, pro vitro. II): Adeps A 3-O-desacyl-4’-monophosphorylatus, Quillajae saponariae Molina saponinum purificatum, 1,2-dioleoyl-sn-glycero-3-phosphocholinum, cholesterolum, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. I) et II) corresp.: proteinum prae-fusionatum F viri sincitialis respiratorii 120 µg, trehalosum dihydricum, polysorbatum 80, kalii dihydrogenophosphas, dikalii phosphas anhydricus, Adeps A 3-O-desacyl-4’-monophosphorylatus, Quillajae saponariae Molina saponinum purificatum, 1,2-dioleoyl-sn-glycero-3-phosphocholinum, cholesterolum, natrii chloridum, dinatrii phosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.78 mg, kalium 0.35 mg.
Articles (1)
AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
120.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
12C
|
120.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
1.78 MG | Substance | HBESI |
|
12C
|
0.35 MG | Substance | HBESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 69310
- Drug name
- AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07BX05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/05/2024
- Authorization expiration date
- 01/05/2029
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AREXVY subst sèche c solv flac
- Description (DE)
- AREXVY Trockensub c Solv Durchstf
- Market launch
- 02/05/2024
- Narcotic (BTM)
- No